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ABSTRACT Pseudomonas aeruginosa is the most common cause of chronic, biofilm-
based lung infections in patients with cystic fibrosis (CF). Sputum from patients with
CF has been shown to contain oxic and hypoxic subzones as well as millimolar con-
centrations of lactate. Here, we describe the physiological roles and expression pat-
terns of P. aeruginosa lactate dehydrogenases in the contexts of different growth re-
gimes. P. aeruginosa produces four enzymes annotated as lactate dehydrogenases,
three of which are known to contribute to anaerobic or aerobic metabolism in liquid
cultures. These three are LdhA, which reduces pyruvate to D-lactate during anaerobic
survival, and LldE and LldD, which oxidize D-lactate and L-lactate, respectively, during
aerobic growth. We demonstrate that the fourth enzyme, LldA, performs redundant
L-lactate oxidation during growth in aerobic cultures in both a defined MOPS (mor-
pholinepropanesulfonic acid)-based medium and synthetic CF sputum media. How-
ever, LldA differs from LldD in that its expression is induced specifically by the
L-enantiomer of lactate. We also show that the P. aeruginosa lactate dehydrogenases
perform functions in colony biofilms that are similar to their functions in liquid cul-
tures. Finally, we provide evidence that the enzymes LdhA and LldE have the poten-
tial to support metabolic cross-feeding in biofilms, where LdhA can catalyze the pro-
duction of D-lactate in the anaerobic zone, which is then used as a substrate in the
aerobic zone. Together, these observations further our understanding of the meta-
bolic pathways that can contribute to P. aeruginosa growth and survival during CF
lung infection.
IMPORTANCE Lactate is thought to serve as a carbon and energy source during
chronic infections. Sites of bacterial colonization can contain two enantiomers of lac-
tate: the L-form, generally produced by the host, and the D-form, which is usually
produced by bacteria, including the pulmonary pathogen Pseudomonas aeruginosa.
Here, we characterize P. aeruginosa’s set of four enzymes that it can use to intercon-
vert pyruvate and lactate, the functions of which depend on the availability of oxy-
gen and specific enantiomers of lactate. We also show that anaerobic pyruvate fer-
mentation triggers production of the aerobic D-lactate dehydrogenase in both liquid
cultures and biofilms, thereby enabling metabolic cross-feeding of lactate over time
and space between subpopulations of cells. These metabolic pathways might con-
tribute to P. aeruginosa growth and survival in the lung.
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During growth and survival in communities, bacteria encounter microniches withconditions that differ from those of the external environment. Gradients form over
biofilm depth due to consumption of resources by cells closer to the periphery (1–3).
Efforts to control biofilm behavior in clinical and industrial settings depend on our
understanding of the physiological responses to these unique conditions.
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We study the effects of biofilm resource gradients on the physiology of the
opportunistic pathogen Pseudomonas aeruginosa, a major cause of biofilm-based in-
fections and the most prominent cause of lung infections in patients with the inherited
disease cystic fibrosis (CF) (4). P. aeruginosa can generate ATP for growth via oxygen
and nitrate respiration and, to a limited extent, through arginine fermentation (5, 6).
Sufficient ATP to support survival can be generated via (i) pyruvate fermentation (7) or
(ii) cyclic reduction of endogenously produced antibiotics called phenazines, under
conditions in which these compounds are reoxidized outside the cell (8, 9). We have
found that some of these pathways for ATP generation also facilitate redox balancing
for cells in biofilms and that P. aeruginosa modulates its overall community architecture
in response to the availability of oxygen, nitrate, and phenazines (1, 10).
Previous work has indicated that phenazine-supported ATP generation and survival
in anaerobic cell suspensions depend on reactions associated with pyruvate fermen-
tation and oxidation (7, 9). Furthermore, lactate, a product of pyruvate fermentation, is
a major component of CF sputum (11) and a significant carbon and energy source for
pathogens and commensals of mammalian hosts (12–15). These observations moti-
vated us to investigate the roles of enzymes that interconvert pyruvate and lactate in
P. aeruginosa growth and biofilm development, including a previously uncharacterized
L-lactate dehydrogenase. We found that this enzyme plays a redundant role in aerobic
growth on L-lactate but that its expression is uniquely and specifically induced by the
L-enantiomer of lactate, which is typically produced by plant and mammalian meta-
bolism (16–18). Our studies also show that biofilms grown on pyruvate have the
potential to engage in substrate cross-feeding, in which D-lactate produced fermenta-
tively in the anoxic microniche acts as the electron donor for aerobic respiration in the
upper, oxic portion of the biofilm. These results help us to further define potential
pathways of electron flow in P. aeruginosa biofilm cells and the diverse metabolisms
that might operate simultaneously in bacterial communities.
RESULTS AND DISCUSSION
The P. aeruginosa genome encodes four enzymes that interconvert pyruvate
and lactate. To initiate our characterization of pathways for pyruvate and lactate
utilization in P. aeruginosa PA14, we examined the genome for loci encoding lactate
dehydrogenases. PA14 contains four genes with the following annotation: ldhA (PA14_
52270), lldD (PA14_63090), lldE (PA14_63100), and lldA (PA14_33860) (Fig. 1). ldhA
encodes a lactate dehydrogenase that reduces pyruvate to lactate during anaerobic
pyruvate fermentation (7) (Fig. 1). According to computational prediction (19), ldhA is
cotranscribed with three other genes, including that encoding the global regulator
GacS. lldD and lldE encode an L-lactate dehydrogenase and a D-lactate dehydrogenase,












FIG 1 The P. aeruginosa genome encodes several enzymes that interconvert pyruvate and lactate. (Left)
Reactions catalyzed by P. aeruginosa’s lactate dehydrogenases; (right) chromosomal loci encoding each
of the corresponding enzymes. LdhA catalyzes the reduction of pyruvate during anaerobic survival. LldE
catalyzes the oxidation of D-lactate during aerobic growth. Unlike E. coli, which contains only one gene
encoding an L-lactate dehydrogenase, P. aeruginosa contains two orthologues for this enzyme. LldD
catalyzes the oxidation of L-lactate during aerobic growth. This study describes a role for LldA in
catalyzing the oxidation of L-lactate during aerobic growth.
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which encodes a repressor of lldPDE expression that is deactivated by either L- or
D-lactate, lies adjacent to the lldPDE operon and is divergently transcribed (Fig. 1) (20).
P. aeruginosa PA14 encodes a second, uncharacterized L-lactate dehydrogenase, called
LldA, that is 44% identical to LldD. Though few other pseudomonad species contain
more than one L-lactate dehydrogenase (see Fig. S1A to C in the supplemental material)
(19), the P. aeruginosa arrangement of lldR and lldPDE (Fig. S1B) is common within the
Pseudomonas genus. In the model organism Escherichia coli, by contrast, the lldPRD
genes are arranged in an operon and lldR responds specifically to L-lactate (21), while
the E. coli D-lactate dehydrogenase Dld is encoded separately (Fig. S1D) (22).
The lldPDE and lldA loci are induced by substrates of their respective protein
products. Upon noticing the second gene encoding an L-lactate dehydrogenase (i.e.,
LldA) in the P. aeruginosa genome, we wondered whether we could observe its
expression under conditions similar to those that induce the expression of LldD. We
therefore created a suite of P. aeruginosa PA14 strains that express green fluorescent
protein (GFP) under the control of putative promoters for lactate dehydrogenase genes.
For the lldPDE and lldA reporters, we treated 300 bp of sequence upstream of each of
these loci as putative promoters. However, we viewed ldhA as a unique case because
it was computationally predicted to be cotranscribed with gacS. GacS is a notorious
upstream regulator of quorum sensing (23) and therefore plays a role in P. aeruginosa
physiology distinct from that of ldhA. We examined transcriptome sequencing (RNA-
seq) data obtained from PA14 biofilms to identify transcriptional start sites in the
gacS-ldhA region of the genome. This profiling showed a transcriptional start site at
46 bp upstream of the start codon of gacS and steady numbers of reads extending
through ldhA (Fig. S2A), suggesting that ldhA expression is driven by the promoter
upstream of gacS. Nevertheless, we created reporter strains that contained portions of
sequence from the regions upstream of either gacS or ldhA, respectively, so that we
could detect any potential, independent expression of ldhA.
The reporter strains were grown aerobically in defined media. We observed very low
levels of expression from the gacS promoter, but not the putative ldhA promoter
region, as predicted from the RNA-seq profiling (Fig. S2B). Cotranscription of gacS and
ldhA makes physiological sense in that the high cell density associated with quorum
sensing leads to oxygen limitation and therefore a condition in which cells potentially
benefit from pyruvate fermentation. A low level of expression was also observed after
9 h of growth for lldPDE, but not lldA, on D-glucose (left panel of Fig. 2). lldPDE
expression was strongly induced from the start of growth and peaked around 4 h, when
either D- or L-lactate was provided as the sole carbon source (middle and right panels
of Fig. 2). These results are consistent with a previous study of P. aeruginosa XMG (20),
which showed that LldR responds to both enantiomers of lactate. In contrast, lldA
























FIG 2 Expression of loci associated with pyruvate and lactate metabolism during aerobic, liquid-culture
growth. Strains engineered to express GFP under the control of promoters upstream of lldP (which is
cotranscribed with lldD and lldE) or lldA were grown in MOPS medium, with the indicated compounds
provided as sole carbon sources. Background fluorescence from a strain with a promoterless reporter was
subtracted before normalization to the OD at 500 nm. Error bars, which are often obscured by the point
markers, represent the standard deviations from biological triplicates. AU, arbitrary units.
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L-lactate (Fig. 2). This finding is consistent with LldA’s predicted physiological function
and indicates that it is controlled by a regulator that specifically senses the
L-enantiomer. In contrast to that of lldPDE, lldA expression showed a more gradual
increase over the first several hours of growth and peaked at around 14 h.
Both LldD and LldA contribute to L-lactate utilization during liquid-culture and
biofilm growth. To test whether LldA contributes uniquely to L-lactate utilization, we
generated deletion strains lacking lldDE, lldA, or both loci and tested their abilities to
grow aerobically in defined media. When L-lactate was provided as the sole carbon
source, deletion of lldDE did not completely abolish growth but rather led to biphasic
growth at lower rates than that observed for the wild type (Fig. 3A). This slow growth
of the ΔlldDE mutant on L-lactate contrasts with that seen for an equivalent mutant
created in Pseudomonas stutzeri SDM, which shows no growth on L-lactate (24), and
indicates that LldD is not the only enzyme that oxidizes L-lactate in P. aeruginosa.
Indeed, deletion of lldA in the ΔlldDE background yielded a strain that was completely
defective in growth on L-lactate (Fig. 3A). However, the ΔlldA single deletion did not
result in any growth defect on L-lactate (Fig. 3A), suggesting that LldA’s activity is
redundant with that of LldD. Consistent with findings reported for P. stutzeri SDM (24),
we found that lldDE was necessary for growth with D-lactate (Fig. 3A), indicating that
LldE is the only enzyme that oxidizes this enantiomer of lactate during aerobic growth.
The D- and L-enantiomers of lactate are generally associated with bacterial and
metazoan metabolism, respectively, with L-lactate being the primary form produced in
sites of microbial colonization, such as the mammalian gut (13) and the airways of
patients with CF (25). We were therefore interested in the relevance of lactate dehy-






































WT ∆lldDE ∆lldA ∆lldDE∆lldA∆ldhA
FIG 3 Physiological roles of enzymes that interconvert pyruvate and lactate during growth in shaken liquid
cultures and biofilms. (A) Aerobic growth of the indicated strains in MOPS medium with D-glucose, L-lactate,
or D-lactate provided as the sole carbon source. Error bars, which are obscured by the point marker in most
cases, represent the standard deviations from biological triplicates. (B) Growth and morphological devel-
opment of the indicated strains under an oxic atmosphere on MOPS medium containing the dyes Congo
red and Coomassie blue and amended with D-glucose, L-lactate, or D-lactate. Images were taken after 4 days
of incubation. WT, wild type.
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major lifestyle assumed by commensal and pathogenic bacteria. To examine this, we
grew deletion mutants lacking lactate dehydrogenase genes as colony biofilms on
defined media containing the dyes Congo red and Coomassie blue, which aid visual-
ization of morphogenetic features. Generally, the colony biofilm phenotypes of the
mutants matched phenotypes observed during aerobic growth in liquid cultures
(Fig. 3B). The lack of an effect of ldhA deletion (Fig. 3B) under these conditions is
consistent with the role of LdhA as a pyruvate reductase (7). We note that, in addition
to having its expected, moderate growth defect on L-lactate, the ΔlldDE mutant showed
increased production of matrix (as indicated by increased binding of Congo red)
(Fig. 3B). In other work (1), we have found that this phenotype often correlates with
impaired redox balancing and a reduced cellular redox state; in this case, therefore, it
might indicate that the LldA enzyme does not sufficiently support the maintenance of
redox homeostasis in colony biofilms.
The L-lactate in synthetic cystic fibrosis media contributes to PA14 growth.
Lactate is a major component of CF sputum (11), and its concentration correlates with
the exacerbation of chronic infections in CF lungs (25). We predicted that LldD and/or
LldA would contribute to PA14 growth in synthetic CF sputum media (11, 26, 27), which
contain millimolar concentrations of L-lactate. We grew mutants lacking these L-lactate
dehydrogenases in three different media that imitate nutrient availability in CF lungs:
(i) synthetic CF sputum medium (SCFM), (ii) modified artificial sputum medium
(ASMDM, which is similar to SCFM but also contains bovine serum albumin [BSA],
mucin, and herring sperm DNA), and (iii) SCFM2, which is similar to ASMDM but
contains additional large molecules. We found that the ΔlldDE ΔlldA double mutant,
which is not able to grow using L-lactate as a sole carbon source (Fig. 3), showed an
10% decrease in growth (Fig. 4A) in SCFM, which was evident after cultures entered
late stationary phase (Fig. 4A and S3). Both lldPDE and lldA were transcriptionally
induced in SCFM, though lldPDE was expressed at a higher level than lldA (Fig. 4B). We
also detected a marked defect for the double mutant in ASMDM, though interestingly,
it occurred earlier in the growth curve (Fig. S3). A modest defect was also detectable in
SCFM2 (Fig. S3). These results suggest that LldD and LldA together might contribute to
L-lactate utilization for growth in the CF lung environment. Our observations indicate
that lactate dehydrogenases make less significant contributions to growth in a more
complex medium containing some of the large molecules and polymers available in
this setting; however, the CF lung environment is heterogeneous and might neverthe-
less contain subregions where lactate is a major source of carbon and energy.
LldE supports the growth of PA14 on self-produced D-lactate. The fact that the





































FIG 4 PA14 utilizes the L-lactate in synthetic cystic fibrosis sputum medium (SCFM) for growth. (A)
Growth of the indicated strains in SCFM. Error bars represent the standard deviations from at least four
biological replicates and are omitted in cases where they would be obscured by point markers. P values
of the ΔlldDE ΔlldA double mutant versus the wild type and ΔlldDE ΔlldA::lldDE strain are 0.0001 based
on an unpaired, two-tailed t test. (B) Expression of the indicated reporter constructs in SCFM. Background
fluorescence from a strain with a promoterless reporter was subtracted before normalization to the OD
at 500 nm.
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version of pyruvate and D-lactate raises the possibility that cells in environments where
oxygen availability varies over time or space engage in metabolic cross-feeding. In this
scenario, pyruvate is reduced to D-lactate under anoxic conditions, and then D-lactate
is oxidized to pyruvate and further metabolized under oxic conditions. We set out to
test this possibility in liquid cultures by first incubating P. aeruginosa anaerobically with
pyruvate (to stimulate D-lactate production) and then using the supernatant from these
cultures as the medium for aerobic growth of fresh cultures (which should use the
D-lactate in an lldE-dependent manner) (Fig. 5A). First, we verified that ldhA supports
the survival of PA14 under anaerobic conditions in which pyruvate is provided as the
major carbon source (Fig. S4). We found that this phenomenon required the inclusion
of a complex nutrient source (e.g., lysogeny broth [LB] or tryptone) in the medium,
possibly as a source of an unidentified cofactor used in pyruvate fermentation. We
therefore carried out a series of titration experiments in order to identify a concentra-
tion of tryptone that would allow us to observe lldE-dependent growth (Fig. S5A) and
lldPDE expression (Fig. S5B) at concentrations of lactate that could be produced in the
pyruvate fermentation cultures (7). Next, we incubated PA14 cells for 7 days in anoxic
liquid 0.1% tryptone medium containing 40 mM pyruvate, collected cell-free spent
medium from these cultures, and used it as the growth medium for freshly inoculated
aerobic cultures (Fig. 5A). Consistent with the model in which PA14-generated D-lactate
was present in the medium and acted as a carbon source (Fig. 5A), this experimental
design yielded high levels of expression from the lldPDE reporter (Fig. 5C) and revealed
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FIG 5 Growth of PA14 on self-produced D-lactate. (A) Design schematic for a pyruvate/D-lactate cross-
feeding experiment in liquid cultures. P. aeruginosa PA14 was incubated in anoxic liquid medium (MOPS
plus 0.1% tryptone plus 40 mM sodium pyruvate) to promote the fermentation and production of
D-lactate. The supernatants collected from these cultures were used as the growth medium for oxic
cultures, in which the D-lactate then served as a carbon source for PA14 growth. (B) Growth of the
indicated strains on supernatants obtained from anaerobic cultures that had fermented pyruvate. Error
bars represent the standard deviations from three biological replicates. P values for the ΔlldDE mutant
versus the wild type, ΔlldA mutant, and ΔldhA mutant are 4.6  104, 2.2  104, and 1.1  103,
respectively, and are based on unpaired, two-tailed t test results with equal variances. (C) Expression of
the indicated reporter constructs during growth on the supernatant described in panel A. Background
fluorescence from a strain with a promoterless reporter was subtracted before normalization to the OD
at 500 nm.
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We next asked whether PA14 has the potential to utilize self-produced D-lactate
during growth in colony biofilms. Colony biofilms were first grown aerobically on
pyruvate for 2 days to establish sufficient biomass and then transferred to fresh anoxic
plates for 2 days to promote pyruvate fermentation and D-lactate production. These
plates were then subsequently moved to oxic conditions and incubated for 1 day
(Fig. 6A). This procedure yielded high expression of the lldPDE reporter (controlled by
an L- and D-lactate sensor) but not the lldA reporter (controlled by an L-lactate-specific
sensor) (Fig. 6B), indicating the presence of self-produced D-lactate, which might
potentially be utilized by PA14 in colony biofilms.
P. aeruginosa PA14 cells in biofilms have the potential to engage in pyruvate/
lactate cross-feeding over the oxygen gradient. As PA14 colony biofilms increase in
thickness, they develop steep oxygen gradients, leading to the formation of metabolic
subpopulations in oxic and anoxic zones (28). After observing that PA14 could produce
D-lactate under fermentative conditions that acts as an electron donor for aerobic
growth, we hypothesized that pyruvate fermentation and aerobic D-lactate utilization
cooccur in biofilms. To test this, we grew colony biofilms on medium with and without
pyruvate and examined the expression of the lldPDE operon, which is induced by
D-lactate. We observed higher expression of lldPDE when colonies were grown on
medium containing pyruvate (Fig. 7A), indicating that cells in the anoxic zone carried
out pyruvate fermentation and produced D-lactate. These results suggest that, in
addition to generating ATP and supporting survival for cells in oxygen-limited regions
of biofilms, pyruvate fermentation can serve to produce D-lactate that supports growth
in regions where oxygen is available (Fig. 7B). Overall, they add a layer of complexity to
our picture of the integrated metabolisms occurring in physiologically heterogeneous
bacterial communities.
Concluding remarks. Metabolic cross-feeding has been described for polymicrobial



























FIG 6 Self-produced D-lactate induces lldPDE in biofilms. (A) Design schematic for a pyruvate/D-lactate
cross-feeding experiment in liquid cultures in colony biofilms. Colonies were initially grown atop filter
membranes on plates containing 1% tryptone, 1% agar plus 40 mM sodium pyruvate for 2 days under an
oxic atmosphere to establish biomass and then transferred to fresh plates of medium containing 0.1%
tryptone, 1% agar plus 40 mM sodium pyruvate in an anoxic chamber to stimulate pyruvate fermentation
and D-lactate production for 2 days. Finally, the plates were moved from the chamber and back into an
oxic atmosphere for 1 day. The procedure was carried out at room temperature. (B) Fluorescence
quantification (top) and images (bottom) of colonies grown using the procedure shown in panel A.
Background fluorescence was normalized to the “no reporter” control. Error bars represent the standard
deviations from three biological replicates. P values for lldPDE reporter versus no reporter and lldA
reporter are 1.0  104 and 2.3  104, respectively, and are based on unpaired, two-tailed t test results
with equal variance.
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sites such as the oral cavity and large intestine (29, 30). Our findings indicate that
metabolic cross-feeding might take place in a single-species biofilm and arise from
physiological heterogeneity, in which a fermentation product formed in the anaerobic
microniche is oxidized by cells in the aerobic microniche. Our model for this cross-
feeding in biofilms might be viewed as a form of electron shuttling (Fig. 7B), with the
role of D-lactate as an electron carrier between anoxic and oxic subzones showing some
similarities to that of phenazines (1, 8, 28).
Most pseudomonad species have either lldD or lldA for L-lactate utilization (Fig. S1C).




























































FIG 7 Expression of enzymes for interconversion of pyruvate and lactate over biofilm depth. Expression
of ldhA (which catalyzes pyruvate reduction under anaerobic conditions) and lldE (which catalyzes
D-lactate oxidation under aerobic conditions) as reported by promoter-gfp fusions in thin sections from
wild-type PA14 biofilms. Biofilms were grown for 3 days on 1% tryptone medium with or without 10 mM
pyruvate. Quantification of fluorescence over depth is shown at the right. This experiment was repeated
in biological triplicate, and representative results are shown. Cyt cred, with reduced cytochrome c; Cyt cox,
with oxidized cytochrome c.
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orphan lldA encode L-lactate dehydrogenases with redundant functions during growth
in liquid cultures. However, lldA differs from lldD in that it is specifically induced by
L-lactate. The presence of redundant L-lactate dehydrogenases in P. aeruginosa may
represent an adaptation to the host environment, given the fact that host organisms,
such as humans and plants (18, 31, 32), produce primarily the L-enantiomer. Several
studies have implicated L-lactate metabolism in bacterial virulence during infections,
including Salmonella-induced gastroenteritis (13) and gonococcal infection of the
genital tract (12). Our results suggest that LldD and LldA utilize L-lactate in SCFM and
other artificial sputum media to promote PA14 growth (Fig. 4A and Fig. S3). Similarly,
other common CF pathogens encode L-lactate dehydrogenases homologous to LldD
and LldA. Using the P. aeruginosa PA14 LldD, LldA, and LldE protein sequences, we
searched for homologues in representative strains of Achromobacter xylosoxidans,
Burkholderia multivorans, Haemophilus influenzae, and Stenotrophomonas maltophilia
(33–35). We found that H. influenzae and S. maltophilia contain an L-lactate dehydro-
genase homolog but that A. xylosoxidans and B. multivorans, like P. aeruginosa, contain
multiple homologs. As L-lactate is a significant metabolite available in the lungs of CF
patients (11, 25, 36, 37), these enzymes may contribute to the abilities of P. aeruginosa
and other pathogens to colonize and persist in this environment.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Unless otherwise indicated, P. aeruginosa strain UCBPP-
PA14 and mutants thereof (38) were routinely grown in lysogeny broth (LB; 1% tryptone, 1% NaCl, 0.5%
yeast extract) (39) at 37°C with shaking at 250 rpm. Overnight cultures were grown for 16  1 h. For
genetic manipulation, strains were typically grown on LB solidified with 1.5% agar. Strains used in this
study are listed in Table S1 in the supplemental material. In general, liquid precultures served as inocula
for experiments. Overnight precultures for biological replicates were started from separate clonal
colonies on streak plates.
Construction of mutant P. aeruginosa strains. For making markerless deletion mutants in P.
aeruginosa PA14 (Table S1), 1-kb flanking sequences from each side of the target gene were amplified
using the primers listed in Table S2 and inserted into the allelic-replacement vector pMQ30 through gap
repair cloning in Saccharomyces cerevisiae InvSc1 (40). Each plasmid listed in Table S1 was transformed
into Escherichia coli strain UQ950, verified by sequencing, and moved into PA14 using biparental
conjugation. PA14 single recombinants were selected on LB agar plates containing 100 g/ml gentami-
cin. Double recombinants (markerless deletions) were selected on sucrose plates (1% tryptone, 0.5%
yeast extract, 10% sucrose, and 1.5% agar). Genotypes of deletion mutants were verified by PCR.
Combinatorial mutants were constructed by using single mutants as parent strains.
Construction of GFP reporter strains. Transcriptional reporter constructs for the genes ldhA, gacS,
lldP, and lldA were made by fusing their promoter sequences with gfp using primers listed in Table S2.
Respective primers were used to amplify promoter regions (as indicated in Table S1) and to add an SpeI
digest site to the 5= end of the promoter and an XhoI digest site to its 3= end. For the ldhA reporter, an
EcoRI site was used instead of XhoI. Purified PCR products were digested and ligated into the multiple-
cloning site (MCS) upstream of the gfp sequence of pLD2722, which is a derivative of pYL122 (41) and
contains a ribosome-binding site between the MCS and gfp. Plasmids were transformed into E. coli strain
UQ950, verified by sequencing, and moved into PA14 using biparental conjugation. Conjugative transfer
of pLD2722 was conducted with the E. coli strain S17-1 (41). PA14 single recombinants were selected on
M9 minimal medium agar plates (47.8 mM Na2HPO4, 22 mM KH2PO4, 8.6 mM NaCl, 18.6 mM NH4Cl, 1 mM
MgSO4, 0.1 mM CaCl2, 20 mM sodium citrate dihydrate, 1.5% agar) containing 70 g/ml gentamicin. The
plasmid backbone of pLD2722 was resolved from PA14 using Flp-Flp recombination target (FRT)
recombination by introduction of the pFLP2 plasmid (42) and selected on M9 minimal medium agar
plates containing 300 g/ml carbenicillin and further on sucrose plates (1% tryptone, 0.5% yeast extract,
10% sucrose, 1.5% agar). The presence of gfp in the final clones was confirmed by PCR.
Liquid-culture growth assays. Overnight (16-h) precultures were diluted 1:100 in a clear-bottom,
polystyrene black 96-well plate (VWR 82050-756), with each well containing 200 l of medium. Cultures
were then incubated at 37°C with continuous shaking at medium speed in a BioTek Synergy 4 plate
reader. Reporter strains were grown in MOPS medium (50 mM MOPS, 43 mM NaCl, 93 mM NH4Cl, 2.2 mM
KH2PO4, 1 mM MgSO4, 1 g/ml FeSO4 at pH 7.0) amended with one of the following carbon sources:
20 mM D-glucose, 40 mM L-lactate, or 40 mM D-lactate (Sigma-Aldrich). Expression of GFP was assessed
by taking fluorescence readings at excitation and emission wavelengths of 480 nm and 510 nm, respec-
tively, every 30 min for up to 24 h. Growth was assessed by taking readings of optical density at 500 nm
(OD500) simultaneously with the fluorescence readings.
Colony growth assays. Overnight (16-h) precultures were diluted 1:10 in phosphate-buffered saline
(PBS). Five microliters of diluted cultures was spotted onto MOPS medium (50 mM MOPS, 43 mM NaCl,
93 mM NH4Cl, 2.2 mM KH2PO4, 1 mM MgSO4, 1 g/ml FeSO4 at pH 7.0) amended with one of the
following carbon sources: 20 mM D-glucose, 40 mM L-lactate, or 40 mM D-lactate (Sigma-Aldrich). The
culture medium was then solidified with 1% agar (Teknova). Colonies were incubated at 25°C for up to
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4 days and imaged with an Epson Expression 11000XL scanner. Fluorescence images (Fig. 6B) were taken
with a Zeiss Axio Zoom.V16 microscope (excitation, 488 nm; emission, 509 nm for imaging of GFP
fluorescence).
Anaerobic survival assays. For each anaerobic liquid sample, 50 l of overnight (16-h) precultures
were diluted in 5 ml of potassium phosphate (100 mM)-buffered (pH 7.4) LB (7, 43) in a Balch tube and
then incubated at 37°C with shaking at 250 rpm for 2.5 h to early to mid-exponential phase (OD500, 0.5).
Balch tubes containing subcultures were then transferred into the anaerobic chamber (80% N2, 15% CO2,
and 5% H2) and sealed with rubber stoppers to maintain anoxia. Anaerobic tubes were incubated with
shaking at 250 rpm at 37°C throughout the period of the survival assay. To measure CFU from the
anaerobic culture, 10 to 50 l of culture was aspirated from the tube with a 1-ml syringe (Care Touch)
fitted with a 23-gauge needle (Becton, Dickinson), and then serially diluted in LB down to 106 CFU and
plated on 1% tryptone plates for CFU counting.
Thin sectioning and preparation for microscopic analyses. Thin sections of P. aeruginosa colonies
were prepared as described previously (44). Briefly, to produce bilayer plates, a 4.5-mm-thick bottom
layer of medium (1% agar,1% tryptone) was poured and allowed to solidify before a 1.5-mm-thick top
layer was poured. Precultures were incubated overnight, diluted 1:100 in LB, and incubated until early to
mid-exponential phase (OD500, 0.5). Five microliters of culture were spotted onto the top agar layer and
incubated in the dark at 25°C with 90% humidity (Percival CU-22L) for up to 3 days. Colonies were
sacrificed for thin sectioning at specified time points by first covering them with a 1.5-mm-thick layer of
1% agar, which sandwiches each colony between two 1.5-mm layers of solidified agar. Sandwiched
colonies were lifted from the bottom layer of agar and soaked in 50 mM L-lysine in PBS (pH 7.4) at 4°C
for 4 h, fixed in 4% formaldehyde–50 mM L-lysine–PBS (pH 7.4) at 4°C for 4 h, and then incubated in the
fixative overnight at 37°C. Fixed colonies were washed twice in PBS and dehydrated through a series of
ethanol washes (25%, 50%, 70%, and 95% ethanol in PBS and 3 times with 100% ethanol) for 1 h each
and then cleared by means of three 1-h washes in Histo-Clear-II (National Diagnostics HS-202). Cleared
colonies were infiltrated with paraffin wax (Electron Microscopy Sciences; Fisher Scientific 50-276-89) at
55°C twice for 2 h each. Infiltrated colonies were solidified by overnight incubation at 4°C. Sections were
cut perpendicularly to the base of the colony in 10-m slices using an automatic microtome (Thermo
Fisher Scientific 905200ER), floated over a water bath at 45°C, collected onto slides, and air-dried
overnight. Dried slides were heat-fixed on a hotplate at 45°C for 1 h and then rehydrated to PBS by
reversing the dehydration steps listed above. Sections were then immediately mounted beneath a
coverslip in Tris-buffered DAPI (4=,6-diamidino-2-phenylindole)–Fluoro-Gel (Electron Microscopy Sci-
ences; Fisher Scientific 50-246-93). Differential interference contrast (DIC) and fluorescent confocal
images were captured for at least three biological replicates of each strain using an LSM700 confocal
microscope (Zeiss).
RNA-seq analysis. Δphz (45) colonies were grown on filter membranes (0.2-m pore size, 25-mm
diameter; Whatman) placed on 1% tryptone, 1.5% agar at 25°C for 76 h. Colonies were treated with
RNAprotect bacterial reagent (Qiagen), samples were excised by microscopic laser dissection, and RNA
was extracted using the RNeasy plant minikit (Qiagen). RNA samples were processed by Genewiz,
including rRNA depletion and dUTP incorporation for strand-specific sequencing (Illumina HiSeq 2500
platform). Sixteen fastq files were mapped to the reference PA14 genome using Bowtie2 (46) with an
97% success rate to generate SAM (sequence alignment map) files. SAM files containing 2  108
reads in total were merged, sorted, and indexed with SAMtools (47). Read coverage was visualized with
Integrative Genomics Viewer (IGV) software (48).
Preparation of synthetic SCFM and derivatives. Cystic fibrosis sputum medium (SCFM) was
prepared as described previously (11). SCFM contains the following ingredients: 2.28 mM NH4Cl,
14.94 mM KCl, 51.85 mM NaCl, 10 mM MOPS, 1.3 mM NaH2PO4, 1.25 mM Na2HPO4, 0.348 mM KNO3,
0.271 mM K2SO4, 1.754 mM CaCl2, 0.606 mM MgCl2, 0.0036 mM FeSO4, 3 mM D-glucose, 9.3 mM sodium
L-lactate, 0.827 mM L-aspartate, 1.072 mM L-threonine, 1.446 mM L-serine, 1.549 mM L-glutamate·HCl,
1.661 mM L-proline, 1.203 mM glycine, 1.78 mM L-alanine, 0.16 mM L-cysteine·HCl, 1.117 mM L-valine,
0.633 mM L-methionine, 1.12 mM L-isoleucine, 1.609 mM L-leucine, 0.802 mM L-tyrosine, 0.53 mM
L-phenylalanine, 0.676 mM L-ornithine·HCl, 2.128 mM L-lysine·HCl, 0.519 mM L-histidine·HCl, 0.013 mM
L-tryptophan, and 0.306 mM L-arginine·HCl. Depending on the solubility of the various salts, concentra-
tions of their stock solutions ranged from 0.2 M to 1 M. Stock concentrations for D-glucose and sodium
L-lactate were 1 M and for amino acid stocks 0.1 mM. No stock solution was prepared for L-tyrosine or
L-tryptophan due to poor solubility. The pH of SCFM was adjusted to 6.5 with KOH and sterilized by
filtration (Thermo Scientific Nalgene Rapid-Flow). ASMDM was prepared as previously described (26) by
supplementing SCFM with 10 mg/ml bovine serum albumin, 10 mg/ml mucin from porcine stomach, and
1.4 mg/ml herring sperm DNA. SCFM2 was prepared by supplementing SCFM with 5 mg/ml mucin from
porcine stomach, 100 g/ml 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 300 M N-acetyl-D-
glucosamine, and 600 g/ml herring sperm DNA as previously described (27).
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
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FIG S1, EPS file, 1.6 MB.
FIG S2, EPS file, 1.8 MB.
FIG S3, EPS file, 2.1 MB.
FIG S4, EPS file, 1.2 MB.
Lin et al. ®
September/October 2018 Volume 9 Issue 5 e00961-18 mbio.asm.org 10
 on N
ovem








FIG S5, EPS file, 2.2 MB.
TABLE S1, PDF file, 0.3 MB.
TABLE S2, PDF file, 0.1 MB.
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